홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SPRY
#2601
ARS Pharmaceuticals, Inc. Common Stock
8.140
0
USD
+1.75%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.75%
월간 변동
-3.10%
6달 변화
-11.62%
년간 변동율
-11.62%
이전 종가
8.000
0
Open
8.140
0
Bid
Ask
Low
8.140
0
High
8.140
0
양
64
마켓
주식
헬스케어
SPRY
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
35.14 M
94.4 M
96.5 M
98.12 M
99.3 M
—
Valuation ratios
Enterprise value
—
584.84 M
467.51 M
984.35 M
1.21 B
5.11 B
Price to earnings ratio
—
-9.68
-9.79
131.88
-6.7
-133.34
Price to sales ratio
—
255.65
17.71 K
12.12
13.63
49.67
Price to cash flow ratio
—
-8.39
-8.96
79.73
-6.72
-104.24
Price to book ratio
—
1.23
2.3
4.21
10.05
14.61
EBITDA 비율에 대한 기업 가치
—
—
-6.93
-338.96
-5.99
-82.31
Profitability ratios
Return on assets %
-0.27
-0.12
-0.23
0.02
-0.52
-0.51
Return on equity %
-0.29
-0.13
-0.24
0.03
-1.5
-1.09
Return on invested capital %
-490.45
-367.52
-7 803.52
-118.26
-2 307.86
—
Gross margin %
100
100
100
100
97.44
400
Operating margin %
-84.51 K
-2 698.78
-225.07 K
-3.46
-212.92
-1 080.53
EBITDA margin %
-83.67 K
—
-224.82 K
-3.26
-221.09
-1 083.36
Net margin %
-84.41 K
-2 635.41
-181.22 K
8.97
-203.25
-1 015.77
Liquidity ratios
Quick ratio
—
—
—
14.04
6.48
29.14
Current ratio
17.56
51.01
96.92
14.26
7.28
31.11
Inventory turnover
—
—
—
0
0.12
—
Asset turnover
0
0
0
0.31
0.25
0.25
Solvency ratios
Debt to assets ratio
0.02
0
—
—
0.29
—
Debt to equity ratio
0.02
0
—
—
0.84
—
Long term debt to total assets ratio
0
0
—
—
0.29
—
Long term debt to total equity ratio
0
0
—
—
0.84
—
Per share metrics
Operating cash flow per share
—
-1
-0.62
0.13
-1.73
-1.74
EBIT per share
—
-0.89
-0.71
-0.03
-1.84
-1.82
EBITDA per share
—
—
-0.71
-0.03
-1.89
-1.83
Total debt per share
—
0.01
—
—
0.98
—
Cash per share
—
6.87
2.4
3.07
2.49
10.66
Net current asset value per share
—
6.95
2.43
3.26
2.89
12.28
Tangible book value per share
—
6.83
2.42
2.44
1.01
6.44
Working capital per share
—
6.81
2.41
3.04
2.49
10.62
Book value per share
—
6.83
2.42
2.51
1.16
6.94
뉴스
ARS Pharmaceuticals: Neffy's Slow Launch, No Guidance For 2026 Keep Me On Sidelines (SPRY)
린크, ARS 제약 목표 주가 상향…매출 확대 전망
Leerink raises ARS Pharmaceuticals stock price target on sales expansion
ARS Pharmaceuticals, 4분기 전망치 상회…주가 상승
Earnings call transcript: ARS Pharmaceuticals beats Q4 2025 forecasts, stock rises
ARS Pharmaceuticals, Inc. (SPRY) Q4 2025 Earnings Call Transcript
ARS Pharmaceuticals Q1 실적, 수익 예상치를 넘어
ARS Pharmaceuticals earnings beat by $0.01, revenue topped estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates
Canadian Natural to Report Q4 Earnings: What's in the Offing?
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
ARS 제약, Raymond James "강력 매수" 의견 유지